Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Garrido-Rodriguez P, Carmena-Bargueno M, de la Morena-Barrio ME, Bravo-Perez C, de la Morena-Barrio B, Cifuentes-Riquelme R, Lozano ML, Perez-Sanchez H, Corral J. Analysis of AlphaFold and molecular dynamics structure predictions of mutations in serpins. PLoS One. 2024 Jul 5;19(7):e0304451. doi: 10.1371/journal.pone.0304451. eCollection 2024. PubMed PMID: 38968282; PubMed Central PMCID: PMC11226102.
AÑO: 2024; IF: 2.6
Contreras-Toledo D, Jimenez-Fonseca P, Lopez CL, Montes AF, Lopez Munoz AM, Vazquez Rivera F, Alonso V, Alcaide J, Salva F, Covela Rua M, Guillot M, Martin Carnicero A, Jimeno Mate R, Cameselle Garcia S, Asensio Martinez E, Gonzalez Astorga B, Fernandez-Diaz AB, Gonzalez Villaroel P, Virgili Manrique AC, Melian Sosa M, Alonso B, Cousillas Castineiras A, Castanon Lopez C, Aparicio J, Carmona-Bayonas A. Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist? Br J Cancer. 2024 Mar;130(5):777-787. doi: 10.1038/s41416-023-02563-w. Epub 2024 Jan 8. PubMed PMID: 38191609; PubMed Central PMCID: PMC10912758.
AÑO: 2024; IF: 6.8
Soler-Espejo E, Rivera-Caravaca JM, Bru-Canovas JD, Esteve-Pastor MA, Lip GYH, Marin F, Roldan V. Patients with atrial fibrillation and common exclusion criteria from clinical trials are at high risk of clinical events: the Murcia AF Project II (MAFP-II) cohort study. Intern Emerg Med. 2024 Oct;19(7):1941-1948. doi: 10.1007/s11739-024-03701-9. Epub 2024 Jul 4. PubMed PMID: 38965203; PubMed Central PMCID: PMC11467067.
AÑO: 2024; IF: 3.8
Teruel-Montoya R, Rivera J, Lozano ML. The importance of genetic variant cleaners: From patient to wet lab and back to clinical practice. Br J Haematol. 2024 Dec;205(6):2122-2124. doi: 10.1111/bjh.19818. Epub 2024 Oct 7. PubMed PMID: 39375956.
AÑO: 2024; IF: 3.8
Klajmon A, Natorska J, Corral J, de la Morena-Barrio ME, Bravo-Perez C, Kopytek M, Jankowska U, Skupien-Rabian B, Hanarz M, Trelinski J, Zabczyk M. Reduced Plasma Selenoprotein P Is Associated With Type I Antithrombin Deficiency and a Prothrombotic State. Arch Pathol Lab Med. 2024 Sep 13. doi: 10.5858/arpa.2024-0162-OA. Online ahead of print. PubMed PMID: 39265995.
AÑO: 2024; IF: 3.2
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL